Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
14176
PUT
Petrobras Class A
PBR.A
$126B
| $1.18K | ﹤0.01% |
100
-900
| -90% | -$11.6K |
2024 Q3
1 quarter
|
|
14177
PUT
Mind CTI
MNDO
$20.4M
| $1.18K | ﹤0.01% |
+600
| New | +$1.19K |
2024 Q4
0 quarters
|
|
14178
PUT
The ONE Group
STKS
$49.4M
| $1.16K | ﹤0.01% |
400
-3,800
| -90% | -$12.6K |
2024 Q2
2 quarters
|
|
14179
PUT
Cricut
CRCT
$1.37B
| $1.14K | ﹤0.01% |
200
-8,800
| -98% | -$52.8K |
2021 Q3
13 quarters
|
|
14180
Cingulate Inc Warrants
CINGW
$18.2K
| $1.13K | ﹤0.01% |
14,654
-4,825
| -25% | -$243 |
2024 Q2
2 quarters
|
|
|
SVIIW
14181
DELISTED
Spring Valley Acquisition Corp II Warrant
SVIIW
| $1.13K | ﹤0.01% |
+21,782
| New | +$769 |
2024 Q4
0 quarters
|
|
|
GPMT
14182
PUT
Granite Point Mortgage Trust
GPMT
$36.7M
| $1.12K | ﹤0.01% |
400
-5,700
| -93% | -$17.9K |
2020 Q1
19 quarters
|
|
|
CTV.WS
14183
DELISTED
Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
| $1.12K | ﹤0.01% |
+10,155
| New | +$820 |
2024 Q4
0 quarters
|
|
|
OCEA
14184
CALL
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
| $1.11K | ﹤0.01% |
2,000
-68,900
| -97% | -$54.3K |
2024 Q1
3 quarters
|
|
14185
CALL
EverCommerce
EVCM
$1.58B
| $1.1K | ﹤0.01% |
+100
| New | +$1.12K |
2024 Q4
0 quarters
|
|
14186
CALL
908 Devices
MASS
$525M
| $1.1K | ﹤0.01% |
500
-13,600
| -96% | -$38.9K |
2021 Q3
13 quarters
|
|
14187
PUT
DiaMedica Therapeutics
DMAC
$444M
| $1.09K | ﹤0.01% |
200
| – | – |
2022 Q4
8 quarters
|
|
|
BLRX
14188
PUT
BioLineRX
BLRX
$11.8M
| $1.08K | ﹤0.01% |
128
-30
| -19% | -$443 |
2023 Q2
6 quarters
|
|
14189
MultiSensor AI Holdings Warrant
MSAIW
| $1.08K | ﹤0.01% |
31,741
-500
| -2% | -$17 |
2023 Q4
4 quarters
|
|
14190
PUT
Rimini Street
RMNI
$396M
| $1.07K | ﹤0.01% |
400
-300
| -43% | -$612 |
2022 Q3
9 quarters
|
|
|
DISTW
14191
DELISTED
Distoken Acquisition Corporation Warrant
DISTW
| $1.06K | ﹤0.01% |
60,179
-1,094
| -2% | -$23 |
2023 Q3
5 quarters
|
|
14192
CALL
Protara Therapeutics
TARA
$160M
| $1.06K | ﹤0.01% |
200
-8,800
| -98% | -$28.4K |
2023 Q4
4 quarters
|
|
|
OCEA
14193
PUT
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
| $1.05K | ﹤0.01% |
1,900
+1,300
| +217% | +$1.02K |
2024 Q1
3 quarters
|
|
14194
IGC Pharma
IGC
$28.4M
| $1.03K | ﹤0.01% |
+3,068
| New | +$1.15K |
2024 Q4
0 quarters
|
|
|
TOUR
14195
PUT
Tuniu
TOUR
$54M
| $1.03K | ﹤0.01% |
100
-90
| -47% | -$1K |
2023 Q4
4 quarters
|
|
|
THRD
14196
CALL
DELISTED
Third Harmonic Bio
THRD
| $1.03K | ﹤0.01% |
100
-7,000
| -99% | -$87.2K |
2024 Q2
2 quarters
|
|
14197
VOC Energy
VOC
$58.1M
| $1.02K | ﹤0.01% |
214
-11,652
| -98% | -$58.4K |
2023 Q3
5 quarters
|
|
|
PPYAW
14198
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
| $1.02K | ﹤0.01% |
50,726
+14,006
| +38% | +$269 |
2024 Q3
1 quarter
|
|
14199
Tenon Medical Inc Warrant
TNONW
$1.51K
| $1.02K | ﹤0.01% |
87,117
-2,649
| -3% | -$56 |
2023 Q3
5 quarters
|
|
|
GURE
14200
PUT
Gulf Resources
GURE
$5.48M
| $1.02K | ﹤0.01% |
180
+150
| +500% | +$1.03K |
2023 Q4
4 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.